Pericardial effusion of HIV-infected patients ? Results of a prospective multicenter cohort study in the era of antiretroviral therapy

Alexander Lind, N Reinsch, K Neuhaus, S Esser, N H Brockmeyer, A Potthoff, S Pankuweit, R Erbel, B Maisch, T Neumann, Alexander Lind, N Reinsch, K Neuhaus, S Esser, N H Brockmeyer, A Potthoff, S Pankuweit, R Erbel, B Maisch, T Neumann

Abstract

Background: Patients with human immunodeficiency virus (HIV) infection have an increased risk of cardiovascular diseases. Previous publications described pericardial effusion as one of the most common HIV-associated cardiac affiliations. The aim of the current study was to investigate if pericardial effusion still has a relevant meaning of HIV-infected patients in the era of antiretroviral therapy.

Methods: The HIV-HEART (HIV-infection and HEART disease) study is a cardiology driven, prospective and multicenter cohort study. Outpatients with a known HIV-infection were recruited during a 20-month period in a consecutive manner from September 2004 to May 2006. The study comprehend classic parameters of HIV-infection, comprising CD4-cell count (cluster of differentiation) and virus load, as well as non-invasive tests of cardiac diseases, including a thorough transthoracic echocardiography.

Results: 802 HIV-infected patients (female: 16.6%) with a mean age of 44.2 ± 10.3 years, were included. Duration of HIV-infection since initial diagnosis was 7.6 ± 5.8 years. Of all participants, 85.2% received antiretroviral therapy. Virus load was detectable in 34.4% and CD4 - cell count was in 12.4% less than 200 cells/μl. Pericardial effusions were present in only two patients of the analysed population. None of the participants had signs of a relevant cardiovascular impairment by pericardial effusion.

Conclusions: Our results demonstrate that the era of antiretroviral therapy goes along with low rates of pericardial effusions in HIV-infected outpatients. Our findings are in contrast to the results of publications, performed before the common use of antiretroviral therapy.

Figures

Figure 1
Figure 1
Pericardial effusion of an asymptomatic HIV-infected subject. The pericardial effusion was first identified by echocardiography in the present study.

References

    1. Fisher SD, Lipshultz SE. In: Heart disease: A text book of cardiovascular medicine. Braunwald E, editor. Philadelphia: WB Saunders; 2001. Cardiovascular abnormalities in hiv-infected individuals; pp. 2211–21.
    1. Jacob AJ, Boon NA. HIV cardiomyopathy: A dark cloud with a silver lining? Br Heart J. 1991;66(1):1–2. doi: 10.1136/hrt.66.1.1.
    1. Heidenreich PA, Eisenberg MJ, Kee LL, Somelofski CA, Hollander H, Schiller NB, Cheitlin MD. Pericardial effusion in AIDS. Incidence and survival. Circulation. 1995;92(11):3229–34.
    1. Fink L, Reichek N, Sutton MG. Cardiac abnormalities in acquired immune deficiency syndrome. Am J Cardiol. 1984;54(8):1161–3. doi: 10.1016/S0002-9149(84)80178-2.
    1. Neumann T, Esser S, Potthoff A, Pankuweit S, Neumann A, Breuckmann F. et al.Prevalence and natural history of heart failure in outpatient hiv-infected subjects: Rationale and design of the HIV-HEART study. Eur J Med Res. 2007;12(6):243–8.
    1. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmüller R, Adler Y. et al.Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the european society of cardiology. Eur Heart J. 2004;25(7):587–610.
    1. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1–19.
    1. Horowitz MS, Schultz CS, Stinson EB, Harrison DC, Popp RL. Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation. 1974;50(2):239–47.
    1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
    1. Velasquez EM, Glancy DL. Cardiovascular disease in patients infected with the human immunodeficiency virus. J La State Med Soc. 2003;155(6):314–24.
    1. Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: A two-dimensional echocardiographic study. J Am Coll Cardiol. 1989;13(5):1030–6. doi: 10.1016/0735-1097(89)90256-8.
    1. Hecht SR, Berger M, Van Tosh A, Croxson S. Unsuspected cardiac abnormalities in the acquired immune deficiency syndrome. An echocardiographic study. Chest. 1989;96(4):805–8. doi: 10.1378/chest.96.4.805.
    1. Akhras F, Dubrey S, Gazzard B, Noble MI. Emerging patterns of heart disease in HIV infected homosexual subjects with and without opportunistic infections; a prospective colour flow doppler echocardiographic study. Eur Heart J. 1994;15(1):68–75.
    1. Cegielski JP, Ramiya K, Lallinger GJ, Mtulia IA, Mbaga IM. Pericardial disease and human immunodeficiency virus in dar es salaam, tanzania. Lancet. 1990;335(8683):209–12. doi: 10.1016/0140-6736(90)90288-G.
    1. Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-saharan africa. Heart. 2007;93(10):1176–83. doi: 10.1136/hrt.2007.127746.
    1. Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, Maartens G. et al.Mortality in patients treated for tuberculous pericarditis in sub-saharan africa. S Afr Med J. 2008;98(1):36–40.
    1. Chyu KY, Birnbaum Y, Naqvi T, Fishbein MC, Siegel RJ. Echocardiographic detection of kaposi's sarcoma causing cardiac tamponade in a patient with acquired immunodeficiency syndrome. Clin Cardiol. 1998;21(2):131–3. doi: 10.1002/clc.4960210217.
    1. Langer E, Mischke U, Stömmer P, Harrer T, Stoll R. Kaposi's sarcoma with pericardial tamponade in AIDS. Dtsch Med Wochenschr. 1988;113(30):1187–90. doi: 10.1055/s-2008-1067791.
    1. Stotka JL, Good CB, Downer WR, Kapoor WN. Pericardial effusion and tamponade due to kaposi's sarcoma in acquired immunodeficiency syndrome. Chest. 1989;95(6):1359–61. doi: 10.1378/chest.95.6.1359.
    1. Theodossiades G, Tsevrenis V, Bellia M, Avgeropoulou A, Nomikos J, Kontopoulou-Griva I. Cardiac tamponade due to post-cardiac injury syndrome in a patient with severe haemophilia A and HIV-1 infection. Haemophilia. 2000;6(5):584–7. doi: 10.1046/j.1365-2516.2000.00399.x.
    1. Rogers JS, Zakaria S, Thom KA, Flammer KM, Kanno M, Mehra MR. Immune reconstitution inflammatory syndrome and human immunodeficiency virus-associated myocarditis. Mayo Clin Proc. 2008;83(11):1275–9. doi: 10.4065/83.11.1275.
    1. Friedman MJ, Sahn DJ, Haber K. Two-Dimensional echocardiography and b-mode ultrasonography for the diagnosis of loculated pericardial effusion. Circulation. 1979;60(7):1644–9.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj